Welcome to our dedicated page for Honest Company SEC filings (Ticker: HNST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Honest Company, Inc. (NASDAQ: HNST) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations as a personal care and baby care company focused on cleanly-formulated and sustainably-designed products. These SEC filings are central resources for understanding the company’s financial condition, strategy and risk profile.
On this page, you can review periodic reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include information on revenue by category, gross margin, operating expenses, net income or loss, cash position and key risk factors. For The Honest Company, these filings also elaborate on its Transformation Pillars—Brand Maximization, Margin Enhancement and Operating Discipline—and how these principles influence spending, pricing, sourcing and channel decisions.
Current reports on Form 8-K are particularly relevant for tracking material events. In 2025, Honest filed Form 8-Ks to furnish earnings press releases for its quarterly results and to describe the launch of its Transformation 2.0: Powering Honest Growth program. That filing outlines expected restructuring costs, projected annualized benefits, the decision to exit certain lower margin, non-strategic categories and channels, and the anticipated timing of these actions.
Investors interested in capital structure, equity compensation and governance can also use SEC filings to review details such as inducement equity grants made under the company’s 2023 Inducement Plan, as disclosed in press releases and supported by related filings. Insider ownership changes, when reported on Forms 3, 4 and 5, offer additional context on transactions by directors and officers.
Stock Titan enhances access to these documents by pairing real-time updates from the SEC’s EDGAR system with AI-powered summaries. These summaries are designed to help readers quickly understand the main points of lengthy filings—such as what is driving changes in profitability, how restructuring programs like Powering Honest Growth are expected to affect costs and revenue, and which risks management highlights—while still allowing direct access to the original forms for deeper analysis.
Katherine Barton, the Chief Growth Officer of Honest Company (HNST), reported a sale of 6,176 shares of common stock on 08/11/2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025, and executed at a weighted average price of $3.89 (individual trade prices ranged from $3.785 to $3.95).
After the reported transactions, the reporting person beneficially owns 926,996 shares, held directly. That total expressly includes 622,833 restricted stock units that are payable in an equivalent number of shares of the issuer's common stock.
The Honest Company (HNST) Form 144 notifies a proposed sale under Rule 144 of 6,176 common shares with an aggregate market value of $24,046.26. The shares were acquired as restricted stock on 05/19/2025 and the filing lists an approximate sale date of 08/11/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. The filing also records that Katherine E Barton sold 21,389 shares on 05/21/2025 for $113,765.95.
The notice provides the basic transactional facts required by Rule 144 but contains no commentary on company operations, material disclosures, or trading plans. It documents the broker, the class of securities, acquisition nature, outstanding shares count of 111,269,491, and recent related sales, giving investors a record of proposed insider selling activity without additional context.
Form 4 filing for The Honest Company, Inc. (HNST) discloses an initial equity award to newly appointed Chief Financial Officer Bruce Curtiss James III. On 1 July 2025, the company granted 202,880 restricted stock units (RSUs) under the 2023 Inducement Plan at a cost basis of $0.00. The RSUs convert to common stock on vesting and increase the executive’s direct beneficial ownership to the same number of shares.
Vesting schedule: 25 % of the award vests on 19 May 2026; the remaining 75 % vests in equal 6.25 % quarterly tranches thereafter, contingent upon continued employment. No derivative securities or sales were reported.
The filing signals a retention-focused compensation structure that more closely aligns the CFO’s incentives with long-term shareholder value. While the share count is modest relative to HNST’s 94 million shares outstanding (≈0.2 % potential dilution), it represents meaningful personal exposure for the executive without immediate cash outlay by the company.